TAUG
$0.03
Tauriga Sciences
$.00
(3.55%)
TAUG
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Friday
Nov 13
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when TAUG reports earnings?
Beat
Meet
Miss

Where is TAUG's stock price going from here?
Up
Flat
Down
Stock chart of TAUG
Analysts
Summary of analysts' recommendations for TAUG
Score
Grade
Pivots
Resistance
$0.03
$0.03
$0.03

$0.03

Support
$0.03
$0.03
$0.03
Tweet
Growth
Description
Tauriga Sciences, Inc. is a diversified life sciences company focused on the development of a proprietary technology platform in the synthetic biology space. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Tauriga Sciences, Inc. is headquartered in Danbury, Connecticut.
Peers
InterCeptRegeneron PharmaceuticalsVertex PharmaceuticalsBioMarin PharmaceuticalZoetisBristol-Myers SquibbJohnson & JohnsonMerck & Co.PfizerUltragenyx Pharmaceutical